Ventralex Vs Stratafix for Primary Ventral Hernias
VPatchPriRCT
Randomised Controlled Trial of Ventralex Hernia Patch Versus Stratafix Suture for Midline Primary Ventral Hernias
1 other identifier
interventional
200
1 country
1
Brief Summary
Randomised controlled trial comparing Ventralex Hernia Patch with Stratafix suture for repair of primary ventral hernias in the midline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2020
CompletedFirst Posted
Study publicly available on registry
April 22, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedJanuary 3, 2025
January 1, 2025
3.9 years
April 19, 2020
January 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Hernia recurrence
Recurrence diagnosed at clinical and/or radiologic examination
One year
Secondary Outcomes (4)
Rate of intra-and postoperative complications
30 days
Rate of seroma development
one year
Persisting pain
One year
Mean number of days postoperative sick leave
30 days
Study Arms (2)
Ventralex
EXPERIMENTALRepair with Ventralex hernia patch in sublay position
Stratafix
ACTIVE COMPARATORRepair with Stratafix suture
Interventions
Eligibility Criteria
You may qualify if:
- Defect 1-4 cm
- Primary ventral hernia in the midline
- BMI\<35
You may not qualify if:
- Defect \>4cm
- BMI\>35
- Recurrent hernia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karlskoga Hospital
Karlskoga, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriel Sandblom, MD, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patient and the staff responsible for the postoperative care of the patient will be masked for the allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 19, 2020
First Posted
April 22, 2020
Study Start
January 1, 2021
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
January 3, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share